Haemophilia

Blood cells
#Haemophilia #Interview #Novo Nordisk #Rare disease

Novo Nordisk: positivity for haemophilia treatment  

DDW Editor Reece Armstrong speaks to Stephanie Seremetis, Chief Medical Officer, Rare Blood Disorders at Novo Nordisk to get her response to the company’s latest study results for its Mim8 antibody. Earlier this year, pharmaceutical company Novo Nordisk announced positive results from Phase I & II clinical trials… Read More

#Exclusive Content #Opinion

Woman with a nose bleed
#Haemophilia #Novo Nordisk #Rare disease

Novo Nordisk announces positive results for haemophilia A antibody  

Novo Nordisk has announced positive interim results for its Mim8 antibody which is being as a treatment for haemophilia A.   Novo Nordisk presented interim results from the Phase I & II FRONTIER1 dose-escalation study at International Society of Thrombosis and Haemostasis Annual Congress… Read More

#News